March 19, 2015

In Vivo

Game’s Up, Pharma/ The New Drug Pricing Dynamics

By Melanie Senior

Hepatitis C drugs may have provided the spark, but cost-pressured payors, empowered consumers, and at-risk providers are adding fuel to the drug pricing fire. The game may be up for pharma firms that try to push prices out of line with perceived value, potential patient volumes, and affordability.

read full article >